NIH-funded research R01 grant

Creating new skin flaps for reconstructive surgery

Official title: Development of engineered fasciocutaneous skin flaps

Funded at Massachusetts General Hospital · NIH-11079600 · Data updated 2026-11-12

This study is working on creating special skin flaps using your own cells to help heal tough wounds from things like birth defects, injuries, or cancer, making surgeries more successful for people who need help with tissue repair.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 15, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$356,378
NIH project number5R01AR082825-03
Project IDNIH-11079600 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with severe tissue defects due to birth defects, trauma, or cancer.

Less likely to help

Patients with minor tissue defects or those who do not require reconstructive surgery may not benefit from this research.

What this research studies

This research focuses on developing engineered fasciocutaneous skin flaps to address complex tissue defects caused by birth defects, trauma, or cancer. The approach aims to create vascularized and blood-compatible flaps using patient-specific cells, which could improve the outcomes of reconstructive surgeries. By overcoming the limitations of current techniques, this project seeks to provide a more effective solution for patients with challenging tissue repair needs. The methodology involves innovative engineering protocols to enhance the viability and functionality of these skin flaps.

Why it matters

Potential benefit: If successful, this research could significantly improve reconstructive surgery outcomes for patients with complex tissue defects.

How similar studies have gone: Previous research has shown promise in the field of engineered tissue flaps, indicating potential for success with this novel approach.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Uygun, Basak Elif — Massachusetts General Hospital
  • Study coordinator: Uygun, Basak Elif

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.